Cargando…

Establishment and characterization of a new spontaneously immortalized ER(−)/PR(−)/HER2(+) human breast cancer cell line, DHSF-BR16

Invasive ductal carcinoma (IDC) constitutes the most frequent malignant cancer endangering women’s health. In this study, a new spontaneously immortalized breast cancer cell line, DHSF-BR16 cells, was isolated from the primary IDC of a 74-years old female patient, treated with neoadjuvant chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nobili, Stefania, Mannini, Antonella, Parenti, Astrid, Raggi, Chiara, Lapucci, Andrea, Chiorino, Giovanna, Paccosi, Sara, Di Gennaro, Paola, Vezzosi, Vania, Romagnoli, Paolo, Susini, Tommaso, Coronnello, Marcella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052418/ https://www.ncbi.nlm.nih.gov/pubmed/33863935 http://dx.doi.org/10.1038/s41598-021-87362-0

Ejemplares similares

Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype
por: Cinci, Lorenzo, et al.
Publicado: (2016)

Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression
por: Vanti, Giulia, et al.
Publicado: (2021)

Expression of FGD3 gene as prognostic factor in young breast cancer patients
por: Renda, Irene, et al.
Publicado: (2019)

Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
por: Hu, Taobo, et al.
Publicado: (2021)

Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis
por: Jung, Jaehag, et al.
Publicado: (2017)

ODP539 AIPB is a Biomarker for ER+/PR+/Her2- Breast Cancers
por: Cubbedge, Chandler, et al.
Publicado: (2022)

3D Visualization of the Dynamic Bidirectional Talk Between ER/PR and Her2 Pathways
por: Lyv, Jiahong, et al.
Publicado: (2021)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

The Association between ER, PR, HER2, and ER−/PR+ Expression and Lung Cancer Subsequent in Breast Cancer Patients: A Retrospective Cohort Study Based on SEER Database
por: Shao, Hong Yu, et al.
Publicado: (2023)

Dexamethasone Promotes a Stem-Like Phenotype in Human Melanoma Cells via Tryptophan 2,3 Dioxygenase
por: Cecchi, Marta, et al.
Publicado: (2022)

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells †
por: Teodori, Elisabetta, et al.
Publicado: (2020)

BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma
por: Kumar, Mohit, et al.
Publicado: (2017)

Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines
por: Paccosi, Sara, et al.
Publicado: (2020)

Immortality
por: Carroll, John
Publicado: (2020)

Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer
por: Tuna, Musaffe, et al.
Publicado: (2010)

The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes
por: Parise, Carol A., et al.
Publicado: (2015)

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
por: Xu, Junnan, et al.
Publicado: (2018)

Low PR in ER(+)/HER2(−) breast cancer: high rates of TP53 mutation and high SUV
por: Ahn, Sung Gwe, et al.
Publicado: (2018)

Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer
por: Chen, Chih-Jung, et al.
Publicado: (2022)

Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells
por: Cecchi, Marta, et al.
Publicado: (2021)

Stimulatory Interactions between Human Coronary Smooth Muscle Cells and Dendritic Cells
por: Paccosi, Sara, et al.
Publicado: (2014)

PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
por: Cizkova, Magdalena, et al.
Publicado: (2012)

Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast Carcinoma
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2011)

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
por: Bauer, Katrina, et al.
Publicado: (2010)

Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study
por: Hussein, Israa A, et al.
Publicado: (2020)

Digital Validation of Breast Biomarkers (ER, PR, AR and HER2) in Cytology Specimens Using Three Different Scanners
por: Salama, Abeer M., et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
por: Du, Feng, et al.
Publicado: (2022)

fHER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions
por: Soares, Maria, et al.
Publicado: (2022)

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance
por: Hu, Xueyang, et al.
Publicado: (2023)

Triumph of the immortality-will
por: Ludendorff, Mathilde Spiess, 1877-1966
Publicado: (1982)

Immortal DNA
por: Tuma, Rabiya S.
Publicado: (2005)

The immortality enzyme.
Publicado: (1995)

The new immortality
por: Dunne, J. W
Publicado: (1938)

Science and Immortality
Publicado: (1904)

The Hope of Immortality
por: Arnold, Edwin
Publicado: (1891)

Immortality of the Eye
Publicado: (1875)

An Immortal Life
Publicado: (1872)

Are Animals Immortal?
por: Underwood, B. F.
Publicado: (1893)

Differentiated cultures of an immortalized human neural progenitor cell line do not replicate prions despite PrP(C) overexpression
por: Slota, Jessy A., et al.
Publicado: (2023)

Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
por: Puri, Vandana, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mjciukpvfgtmld62e3bl90oq4d